Financhill
Back

Linde PLC Vs. Novonesis (Novozymes) B Industry Stock Comparison

Buy
56

LIN
Linde PLC

Last Price:
435.27
Seasonality Move:
2.9%
Sell
37

NVZMF
Novonesis (Novozymes) B

Last Price:
58.00
Seasonality Move:
2.13%
Buy
56
Linde PLC (LIN) is a Buy

Is Linde PLC a Buy, Sell or Hold?

  • The current Linde PLC [LIN] share price is $435.30. The Score for LIN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • LIN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Novonesis (Novozymes) B (NVZMF) is a Sell

Is Novonesis (Novozymes) B a Buy, Sell or Hold?

  • The current Novonesis (Novozymes) B [NVZMF] share price is $58.00. The Score for NVZMF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • NVZMF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LIN Stock Price Chart

What is Linde PLC's stock price today?

  • The Linde PLC share price today is $435.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIN is experiencing slight buying pressure.

NVZMF Stock Price Chart

What is Novonesis (Novozymes) B's stock price today?

  • The Novonesis (Novozymes) B share price today is $58.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVZMF is experiencing selling pressure, which indicates risk of future bearish movement.

LIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.78 Sell
Relative Strength Index (14 RSI): 29.34 Sell
Chaikin Money Flow: 19828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (444.53 - 458.69) Sell
Bollinger Bands (100): (449.83 - 474.23) Sell

NVZMF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 45.6 Sell
Chaikin Money Flow: -8043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.43 - 59.29) Buy
Bollinger Bands (100): (59.03 - 68.35) Sell

LIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 444.9 Sell
20-day SMA: 450.46 Sell
50-day SMA: 461.45 Sell
200-day SMA: 453.54 Sell
8-day EMA: 443.55 Sell
20-day EMA: 449.95 Sell
50-day EMA: 456.85 Sell
200-day EMA: 447.51 Sell

NVZMF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.44 Sell
20-day SMA: 57.73 Buy
50-day SMA: 61.41 Sell
200-day SMA: 61.29 Sell
8-day EMA: 58.42 Sell
20-day EMA: 58.58 Sell
50-day EMA: 60.55 Sell
200-day EMA: 60.4 Sell

Linde PLC Earnings Growth & LIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.47 per share.

Novonesis (Novozymes) B Earnings Growth & NVZMF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Linde PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novonesis (Novozymes) B Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):